Mounjaro/Zepbound (tirzepatide), approved dual GLP-1/GIP agonist for type 2 diabetes and obesity Recent Highlights: In April 2026, the FDA approved orforglipron (Foundayo), making it one of the first oral GLP-1 pills that can be taken any time of day and that has no food or water restrictions
While GLP-1s can be more effective than lifestyle changes alone, including changes to your diet and increasing physical activity, its worth noting that the best approach to using GLP-1s is to combine them with those healthy habits
What is the Direct Meds number for customer support
Doses cant be guaranteed, and they may be mixed with other ingredients that may lead to adverse effects, Isaacs says
Smaller meals, more hydration, and electrolyte supplementation become more important
She then developed prediabetes, high blood pressure and cholesterol, asthma and depression